Summary

Balaji Amines Limited, a leading manufacturer of Aliphatic Amines & Speciality Chemicals in India, announced its audited financial results for the quarter and year ended March 31°, 2025. The company reported a consolidated Q4FY25 revenue of ₹ 361 Cr and a net profit of ₹ 40 Cr. The EBITDA stood at ₹ 68 Cr with an EBITDA margin of 19%.

Key Highlights

1. 1

   Q4FY25 Revenue from Operations stood at ₹ 327 crore

2. 2

   Total volumes for Q4FY25 stood at 24,047 MT

3. 3

   EBITDA for Q4FY25 was ₹ 64 crore with a margin of 20%

4. 4

   PAT for Q4FY25 was ₹ 40 crore

5. 5

   First phase of Solar power plant of 8 MW DC(6 MW AC) is commissioned in April 2025

6. 6

   Existing DMC plant is added with new Equipment for Electronic Grade DMC, commissioned on 28 May, 2025

7. 7

   Propylene Glycol Pharma grade plant is likely to be commissioned in Q1 FY 25-26

8. 8

   Di Methyl Ether plant is under construction and likely to be commissioned in this Financial Year 2025-26

9. 9

   N-Methyl Morpholine(NMM) plant with a capacity of 15 MT/Day is under execution at Unit IV, likely to be commissioned during the Financial Year 2025-26

10. 10

    Iso Propyl Amine plant is likely to be commissioned after receipt of Consent for Operations from MPCB

11. 11

    The company has taken up a project for upgradation of technology and increasing the capacity of existing ACN plant to a capacity of 60 MT/Day at Unit-IIl MIDC, Chincholi, expected to be commissioned during the FY 2026-27

12. 12

    The company is proposing to set up a plant for manufacture of N-(N-Butyl) Thiophosphoric Triamide(NBPT) with a capacity of 2500 TPA in the next Financial Year

13. 13

    New expansion of approx. Rs. 750 crs in Subsidiary Balaji Speciality Chemicals Limited, expected to be commissioned during the end of the FY 2025-26